Metropolitan Life Insurance CO Evelo Biosciences, Inc. Transaction History

Metropolitan Life Insurance CO

  • $281 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$6.79 - $13.9 $60,682 - $124,224
-8,937 Closed
0 $0
Q2 2021

Jun 21, 2023
BUY
$9.43 - $16.6 $84,275 - $148,354
8,937 New
8,937 $122,000
Q2 2021

Mar 30, 2023
BUY
$9.43 - $16.6 $84,275 - $148,354
8,937 New
8,937 $122,000
Q2 2021

Aug 16, 2021
BUY
$9.43 - $16.6 $84,275 - $148,354
8,937 New
8,937 $123,000

About Evelo Biosciences, Inc.

EVLO Quotes by TradingView
  • Ticker EVLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,994,000
  • Description
  • Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...
More about EVLO
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email